Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hypertension × Sunitinib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Renal Cell 13 Gastrointestinal Stromal Tumors 3 Neoplasms 2 Kidney Neoplasms 2 Urogenital Neoplasms 1 Pancreatic Neuroendocrine Tumors 1 Kidney Diseases 1 Hypertension 1 Clear-cell metastatic renal cell carcinoma 1 Carcinoma 1 Adenoma, Islet Cell 1

Interventions

ziprasidone 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Urine Specimen Collection 1 Tranexamic Acid 1 Tobramycin 1 Sunitinib 1 Standard of Care 1 Spironolactone 1 Sevelamer 1 Rocuronium 1 Polymorphism, Genetic 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Nafcillin 1 Molindone 1 Methylprednisolone 1 Lurasidone Hydrochloride 1 Labetalol 1 Hydrochlorothiazide 1 Haloperidol 1 Gastrectomy 1 Fosfomycin 1 Endoscopic Mucosal Resection 1 Electrocardiography 1 Clozapine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04368546 2021-01-27

Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)

Charite University, Berlin, Germany

Hypertension

Data powered by HemOnc (CC BY 4.0) Colophon ⚡